Status:

COMPLETED

Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON

Lead Sponsor:

Fundación Cardiovascular de Colombia

Collaborating Sponsors:

Fundación Santandereana de Diabetes y Obesidad (FUSANDE)

The University of Akron

Conditions:

Diabetic Foot

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Diabetes Mellitus constitutes one of the most important public health problems due to its high prevalence and enormous social and economic consequences. Diabetic foot ulcers are one of the chronic com...

Detailed Description

Background Diabetes Mellitus (DM) constitutes one of the most important public health problems with a worldwide impact due to its high prevalence and enormous social and economic consequences. It is ...

Eligibility Criteria

Inclusion

  • Men and women 18 years or older.
  • Capacity of attending the visits at the research site.
  • Confirmed diagnosis of DM type 1 or 2 according to the guidelines from the American Diabetes Association (ADA).
  • Presence of 1 or more DFU, less than 15cm in its biggest diameter, with a Texas University score ≤2.
  • Pharmacological treatment for glycemic control.
  • Willingness to participate in the study and to sign the informed consent form.

Exclusion

  • Unconfirmed DM diagnosis.
  • Any pathology that, based on the judgment of the researcher, could alter the course of DFU (neoplasias, immunological disorders, etc).
  • Renal insufficiency requiring dialysis treatment.
  • DFU with a Texas score \>2.
  • Infected DFU with clinical or paraclinical findings suggesting osteomyelitis.
  • Critical ischemia of IL diagnosed by Doppler ultrasound and defined by ankle/arm index \< 0.5.
  • Clinical findings suggesting complicated venous insufficiency of IL.
  • Distal necrosis of the limb with the ulcer.
  • Pregnant or breastfeeding women.
  • Mentally or neurologically disabled patients that are considered not fit to approve their participation in the study.
  • Refusal to give informed consent.

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2011

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00428727

Start Date

January 1 2005

End Date

February 1 2011

Last Update

November 6 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fundacion Cardiovascular de Colombia

Bucaramanga, Santander Department, Colombia